Directory
Ana Velasco Sanchez

Ana Velasco Sanchez

Degree: PhD


avelasco(ELIMINAR)@gss.cat

ResearcherID: http://www.researcherid.com/rid/B-5596-2009

Publications

  • Dosil, MA; Navaridas, R; Mirantes, C; Tarragona, J; Eritja, N; Felip, I; Urdanibia, I; Megino, C; Domingo, M; Santacana, M; Gatius, S; Piñol C; Barcelo, C; Maiques, O; Macia, A; Velasco, A; Vaquero, M; Matias-Guiu, X; Dolcet, X

    Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis

    JOURNAL OF PATHOLOGY 247 72-85. .

    [doi:10.1002/path.5168]

  • Fernandez Armenteros, Jose Manuel; Arco Huguet, Nuria; Sanmartin Novell, Veronica; Vilardell Villellas, Felip; Velasco Sanchez, Ana; Martro Catala, Elisa; Marti Laborda, Rosa Maria; Soria Gili, Xavier

    Langerhans cell histiocytosis mimicking molluscum contagiosum: A case series

    PEDIATRIC BLOOD & CANCER 65 -. .

    [doi:10.1002/pbc.27047]

  • Maiques, O; Moreno, S; Romero, M; Santacana, M; Gomez, I; Velasco, A; Macia, A; Barcelo, C; Boix, R; Valls, J; Gatius, S; Canti, C; Matias-Guiu, X; Soria, X; Marti, RM

    Differential immunoexpression of senescence markers, tumor suppressor genes, BRAF-V600E and T-type calcium channels in acquired nevi according to their histopathological and dermoscopic classification

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 31 65-65. .

  • Mateo, F; Arenas, EJ; Aguilar, H; Serra-Musach, J; de Garibay, GR; Boni, J; Maicas, M; Du, S; Iorio, F; Herranz-Ors, C; Islam, A; Prado, X; Llorente, A; Petit, A; Vidal, A; Catala, I; Soler, T; Venturas, G; Rojo-Sebastian, A; Serra, H; Cuadras, D; Blanco, I; Lozano, J; Canals, F; Sieuwerts, AM; de Weerd, V; Look, MP; Puertas, S; Garcia, N; Perkins, AS; Bonifaci, N; Skowron, M; Gomez-Baldo, L; Hernandez, V; Martinez-Aranda, A; Martinez-Iniesta, M; Serrat, X; Ceron, J; Brunet, J; Barretina, MP; Gil, M; Falo, C; Fernandez, A; Morilla, I; Pernas, S; Pla, MJ; Andreu, X; Segui, MA; Ballester, R; Castella, E; Nellist, M; Morales, S; Valls, J; Velasco, A; Matias-Guiu, X; Figueras, A; Sanchez-Mut, JV; Sanchez-Cespedes, M; Cordero, A; Gomez-Miragaya, J; Palomero, L; Gomez, A; Gajewski, TF; Cohen, EEW; Jesiotr, M; Bodnar, L; Quintela-Fandino, M; Lopez-Bigas, N; Valdes-Mas, R; Puente, XS; Viñals F; Casanovas, O; Graupera, M; Hernandez-Losa, J; Ramón Y Cajal S; Garcia-Alonso, L; Saez-Rodriguez, J; Esteller, M; Sierra, A; Martin-Martin, N; Matheu, A; Carracedo, A; Gonzalez-Suarez, E; Nanjundan, M; Cortes, J; Lazaro, C; Odero, MD; Martens, JWM; Moreno-Bueno, G; Barcellos-Hoff, MH; Villanueva, A; Gomis, RR; Pujana, MA

    Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

    ONCOGENE 36 2737-2749. .

    [doi:10.1038/onc.2016.427]

  • Piulats, JM; Guerra, E; Gil-Martin, M; Roman-Canal, B; Gatius, S; Sanz-Pamplona, R; Velasco, A; Vidal, A; Matias-Guiu, X

    Molecular approaches for classifying endometrial carcinoma

    GYNECOLOGIC ONCOLOGY 145 200-207. .

    [doi:10.1016/j.ygyno.2016.12.015]

  • Guerra, E; Vidal, A; Gatius, S; Velasco, A; Piulats, JM; Ponce, J; Tallada, XG; Pardo, B; Martin, MG; Ortega, E; Guiu, XM

    Molecular classification of grade 3 endometrioid endometrial carcinomas: A retrospective study

    VIRCHOWS ARCHIV 469 20-20. .

  • Vaquero, M; Macia, A; Anerillas, C; Velasco, A; Matias-Guiu, X; Ribera, J; Encinas, M

    Sprouty1 haploinsufficiency accelerates pheochromocytoma development in Pten(+/-) mice

    ENDOCRINE-RELATED CANCER 23 7-11. .

    [doi:10.1530/ERC-15-0585]

  • Maiques, O.; Cuevas, D.; García Dios, D.A.; Coenegrachts, L.; Santacana, M.; Velasco, A.; Romero, M.; Gatius, S.; Lambrechts, D.; Müller, S.; Pedersen, H.C.; Dolcet, X.; Amant, F.; Matias-Guiu, X.

    FISH analysis of PTEN in endometrial carcinoma. Comparison with SNP arrays and MLPA

    Histopathology 65 371-388. .

    [doi:10.1111/his.12396]

  • Veà, A.; Barrera, J.; Velasco, A.; Casanova, J.M.; Matias-Guiu, X.; Martí, R.M.

    Utilidad de la siascopia en el diagnóstico de lesiones melanocíticas

    Piel 29 654-659. .

    [doi:10.1016/j.piel.2014.05.003]

  • Azueta, Ainara; Maiques, Oscar; Velasco, Ana; Santacana, Maria; Pallares, Judith; Novell, Anna; Llombart-Cussac, Antonio; Gonzalez-Tallada, Xavier; Mozos, Ana; Prat, Jaime; Pillai, Raji; Mata, Manuel; Matias-Guiu, Xavier

    Gene expression microarray-based assay to determine tumor site of origin in a series of metastatic tumors to the ovary and peritoneal carcinomatosis of suspected gynecologic origin

    HUMAN PATHOLOGY 44 20-28. .

    [doi:10.1016/j.humpath.2012.04.018]

  • Bernet Vegue, Laia; Rojo, Federico; Hardisson, David; Cordoba Iturriagagoitia, Alicia; Jose Panades, Ma; Velasco, Ana; Lopez Bonet, Eugeni; Cano Munoz, Rafael; Polo, Luis; B-CLOSER-I Investigators

    Comparison of Molecular Analysis and Histopathology for Axillary Lymph Node Staging in Primary Breast Cancer: Results of the B-CLOSER-I Study

    Diagnostic Molecular Pathology 21 69-76. .

    [doi:10.1097/PDM.0b013e318241117b]

  • Vilardell, Felip; Novell, Anna; Martin, Javier; Santacana, Maria; Velasco, Ana; Diez-Castro, M. J.; Cuevas, Dolors; Jose Panades, M.; Gonzalez, Serafin; Llombart, Antonio; Iglesias, Edelmiro; Matias-Guiu, Xavier

    Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA

    VIRCHOWS ARCHIV 460 569-575. .

    [doi:10.1007/s00428-012-1241-z]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
  • Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica
  • CARCINOMA DE ENDOMETRIO. VALORACION DELECCIONES Y AMPLIFICACIONES DE REGIONES CROMOSOMICAS MEDIANTE ARRAYS DE CGH